National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- AHRQ Quality Indicator Tools for Data Analytics
- State Snapshots
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies Date
Topics
- (-) Cancer (13)
- Cancer: Breast Cancer (4)
- Cancer: Colorectal Cancer (3)
- Cancer: Prostate Cancer (1)
- Case Study (1)
- Chronic Conditions (1)
- Colonoscopy (1)
- Diagnostic Safety and Quality (2)
- Disabilities (1)
- Disparities (1)
- Elderly (1)
- Family Health and History (1)
- Genetics (2)
- Guidelines (1)
- Healthcare Costs (2)
- Health Information Technology (HIT) (1)
- Imaging (3)
- Medical Expenditure Panel Survey (MEPS) (1)
- Patient Adherence/Compliance (3)
- Prevention (6)
- Primary Care (1)
- Racial and Ethnic Minorities (1)
- Risk (1)
- Rural Health (1)
- (-) Screening (13)
- Shared Decision Making (2)
- U.S. Preventive Services Task Force (USPSTF) (1)
- Vulnerable Populations (1)
- Women (5)
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
1 to 13 of 13 Research Studies DisplayedLevy DE, Munshi VN, Ashburner JM
Health IT-assisted population-based preventive cancer screening: a cost analysis.
The researchers analyzed costs from a randomized trial of 2 health IT strategies to improve cancer screening compared with usual care from the perspective of a primary care network. They found that over the course of the study year, the value of reduced physician time devoted to preventive cancer screening outweighed the costs of the interventions.
AHRQ-funded; HS020308; HS018161.
Citation: Levy DE, Munshi VN, Ashburner JM .
Health IT-assisted population-based preventive cancer screening: a cost analysis.
Am J Manag Care 2015 Dec;21(12):885-91..
Keywords: Health Information Technology (HIT), Cancer, Screening, Prevention, Healthcare Costs
Baker DW, Brown T, Goldman SN
Two-year follow-up of the effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers.
After an earlier outreach intervention achieved 82 percent annual adherence to colorectal cancer (CRC) screening with fecal occult blood testing (FOBT), this study assessed adherence to FOBT after a second outreach. It found that a total of 88.7 percent of patients completed a fecal immunochemical test within 6 months of their second outreach.
AHRQ-funded; HS021141.
Citation: Baker DW, Brown T, Goldman SN .
Two-year follow-up of the effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers.
Cancer Causes Control 2015 Nov;26(11):1685-90. doi: 10.1007/s10552-015-0650-0..
Keywords: Cancer, Cancer: Colorectal Cancer, Patient Adherence/Compliance, Prevention, Screening
Highfield L, Rajan SS, Valerio MA
A non-randomized controlled stepped wedge trial to evaluate the effectiveness of a multi-level mammography intervention in improving appointment adherence in underserved women.
This study evaluated a theoretically based, systematically designed implementation strategy to support adoption and implementation of a patient navigation-based intervention, called Peace of Mind Program (PMP), aimed at improving breast cancer screening among underserved women.. Any potential confounding or bias will be controlled in the analysis. Outcomes such as appointment adherence, patient referral to diagnostics, time to diagnostic referral, patient referral to treatment, time to treatment referral, and budget impact of the intervention will be assessed.
AHRQ-funded; HS023255.
Citation: Highfield L, Rajan SS, Valerio MA .
A non-randomized controlled stepped wedge trial to evaluate the effectiveness of a multi-level mammography intervention in improving appointment adherence in underserved women.
Implement Sci 2015 Oct 14;10:143. doi: 10.1186/s13012-015-0334-x.
.
.
Keywords: Cancer: Breast Cancer, Cancer, Screening, Patient Adherence/Compliance, Women, Vulnerable Populations, Prevention, Imaging
Mortel M, Rauscher GH, Murphy AM
Racial and ethnic disparity in symptomatic breast cancer awareness despite a recent screen: the role of tumor biology and mammography facility characteristics.
In a racially and ethnically diverse sample of recently diagnosed urban patients with breast cancer, the researchers examined associations of patient, tumor biology, and mammography facility characteristics on the probability of symptomatic discovery of their breast cancer despite a recent prior screening mammogram. They concluded that facility resources and tumor aggressiveness explain much of the racial/ethnic disparity in symptomatic breast cancer among recently screened patients.
AHRQ-funded; HS018366.
Citation: Mortel M, Rauscher GH, Murphy AM .
Racial and ethnic disparity in symptomatic breast cancer awareness despite a recent screen: the role of tumor biology and mammography facility characteristics.
Cancer Epidemiol Biomarkers Prev 2015 Oct;24(10):1599-606. doi: 10.1158/1055-9965.epi-15-0305.
.
.
Keywords: Cancer: Breast Cancer, Cancer, Disparities, Women, Racial and Ethnic Minorities, Screening, Prevention
Irvin VL, Breen N, Meissner HI
AHRQ Author: Kaplan RM
Non-normal screening mammography results, lumpectomies, and breast cancer reported by California women, 2001-2009.
This study report trends in self-reported non-normal screening mammography results, lumpectomies, and breast cancer in California women. Between 2001 and 2009, the percent of California women who reported having been diagnosed with breast cancer was relatively stable. For each of the three age groups studied, the percentage of non-normal mammography results increased and the percentages of lumpectomies decreased.
AHRQ-authored.
Citation: Irvin VL, Breen N, Meissner HI .
Non-normal screening mammography results, lumpectomies, and breast cancer reported by California women, 2001-2009.
AHRQ-authored..
Keywords: Cancer: Breast Cancer, Cancer, Screening, Imaging, Women
Gallego CJ, Shirts BH, Bennette CS
Next-generation sequencing panels for the diagnosis of colorectal cancer and polyposis syndromes: a cost-effectiveness analysis.
The researchers evaluated the cost effectiveness of next-generation sequencing (NGS) panels for the diagnosis of colorectal cancer and polyposis (CRCP) syndromes in patients referred to cancer genetics clinics. They concluded that the use of an NGS panel that includes genes associated with highly penetrant CRCP syndromes in addition to Lynch syndrome genes as a first-line test is likely to provide meaningful clinical benefits in a cost-effective manner.
AHRQ-funded; HS021686.
Citation: Gallego CJ, Shirts BH, Bennette CS .
Next-generation sequencing panels for the diagnosis of colorectal cancer and polyposis syndromes: a cost-effectiveness analysis.
J Clin Oncol 2015 Jun 20;33(18):2084-91. doi: 10.1200/jco.2014.59.3665..
Keywords: Cancer, Cancer: Colorectal Cancer, Shared Decision Making, Diagnostic Safety and Quality, Genetics, Healthcare Costs, Screening
Elstad EA, Sutkowi-Hemstreet A, Sheridan SL
Clinicians' perceptions of the benefits and harms of prostate and colorectal cancer screening.
The researchers sought to understand clinicians’ perceptions of the benefits and harms of two screening tests (colonoscopy and prostate-specific antigen (PSA) testing) that differ in their balance of potential benefits and harms. Clinicians perceived PSA testing to have a greater likelihood of harm as well as a lower likelihood of lengthening life relative to colonoscopy.
AHRQ-funded; HS000032; HS021133
Citation: Elstad EA, Sutkowi-Hemstreet A, Sheridan SL .
Clinicians' perceptions of the benefits and harms of prostate and colorectal cancer screening.
Med Decis Making. 2015 May;35(4):467-76. doi: 10.1177/0272989x15569780..
Keywords: Cancer, Cancer: Colorectal Cancer, Colonoscopy, Cancer: Prostate Cancer, Screening
Horner-Johnson W, Dobbertin K, Iezzoni LI
Disparities in receipt of breast and cervical cancer screening for rural women age 18 to 64 with disabilities.
The authors examined the combination of disability status and rurality in association with receipt of breast and cervical cancer screening among women age 18 to 64 in the United States. They found that women with disabilities were less likely to be up to date with mammograms and Pap tests compared with women with no disabilities, and women in rural areas were less likely to have received breast or cervical cancer screening within recommended timeframes. Women with a disability who lived in a rural area were the least likely to be current with screening.
AHRQ-funded; HS022981.
Citation: Horner-Johnson W, Dobbertin K, Iezzoni LI .
Disparities in receipt of breast and cervical cancer screening for rural women age 18 to 64 with disabilities.
Womens Health Issues 2015 May-Jun;25(3):246-53. doi: 10.1016/j.whi.2015.02.004.
.
.
Keywords: Cancer, Disabilities, Medical Expenditure Panel Survey (MEPS), Rural Health, Screening
Gross CP, Fried TR, Tinetti ME
Decision-making and cancer screening: a qualitative study of older adults with multiple chronic conditions.
The researchers sought to understand how older persons with multiple chronic conditions (MCC) approach decisions about cancer screenings. They found that some older persons with MCC employ heuristics which circumvent the traditional quantitative comparison of risks and benefits, providing an important challenge to informed decision making.
AHRQ-funded; HS018598.
Citation: Gross CP, Fried TR, Tinetti ME .
Decision-making and cancer screening: a qualitative study of older adults with multiple chronic conditions.
J Geriatr Oncol 2015 Mar;6(2):93-100. doi: 10.1016/j.jgo.2014.12.001..
Keywords: Cancer, Chronic Conditions, Shared Decision Making, Elderly, Screening
Silver MI, Rositch AF, Burke AE
Patient concerns about human papillomavirus testing and 5-year intervals in routine cervical cancer screening.
The purpose of this study was to explore attitudes toward new cervical cancer screening options and understand factors associated with those beliefs among women in routine gynecologic care. It found that the majority still believed women should be screened every year. Despite this, two-thirds stated that they would be willing to extend screening to every 3 years if their doctor recommended it.
AHRQ-funded; HS022199.
Citation: Silver MI, Rositch AF, Burke AE .
Patient concerns about human papillomavirus testing and 5-year intervals in routine cervical cancer screening.
Obstet Gynecol 2015 Feb;125(2):317-29. doi: 10.1097/aog.0000000000000638..
Keywords: Screening, Guidelines, Cancer, Women
Lee K, Rossi C
AHRQ Author: Lee K
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women.
L.M. is a 37-year-old nonsmoking woman who is not taking any medications and has no significant past medical problems. As breast cancer runs in her family, she is interested in genetic testing for breast cancer. This case study poses three multiple choice questions together with the U.S. Preventive Services Task Force recommendations and related background information.
AHRQ-authored.
Citation: Lee K, Rossi C .
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women.
Am Fam Physician 2015 Jan 15;91(2):119-20.
.
.
Keywords: Cancer, Cancer: Breast Cancer, Case Study, Family Health and History, Genetics, Prevention, Risk, Screening, U.S. Preventive Services Task Force (USPSTF), Women
Carter JL, Coletti RJ, Harris RP
Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods.
The authors conducted a systematic review to identify and evaluate the methods that have been used for measuring overdiagnosis of cancer. Their systematic review highlights the high potential for bias and the reliance on unproven assumptions in modeling studies and studies that quantify overdiagnosis using pathological or imaging characteristics.
AHRQ-funded; HS021133.
Citation: Carter JL, Coletti RJ, Harris RP .
Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods.
BMJ 2015 Jan 7;350:g7773. doi: 10.1136/bmj.g7773..
Keywords: Cancer, Diagnostic Safety and Quality, Imaging, Screening
Phillips L, Hendren S, Humiston S
Improving breast and colon cancer screening rates: a comparison of letters, automated phone calls, or both.
The goal of this study was to understand the differential effects of low-cost automated telephone and mailed interventions on cancer screening rates in a primary care practice. It found that letters plus automated telephone calls are better than either alone in increasing cancer screening rates among patients who are overdue for screening.
AHRQ-funded; HS022440
Citation: Phillips L, Hendren S, Humiston S .
Improving breast and colon cancer screening rates: a comparison of letters, automated phone calls, or both.
J Am Board Fam Med. 2015 Jan-Feb;28(1):46-54. doi: 10.3122/jabfm.2015.01.140174..
Keywords: Primary Care, Screening, Cancer, Prevention, Patient Adherence/Compliance